S&P 500
(-0.34%) 5 018.39 points
Dow Jones
(0.23%) 37 903 points
Nasdaq
(-0.33%) 15 605 points
Oil
(0.54%) $79.43
Gas
(1.14%) $1.954
Gold
(0.71%) $2 327.30
Silver
(0.29%) $26.83
Platinum
(1.34%) $967.70
USD/EUR
(0.04%) $0.933
USD/NOK
(-0.01%) $11.03
USD/GBP
(-0.06%) $0.798
USD/RUB
(0.27%) $93.51

实时更新: CSL Limited [CSLLY]

交易所: OTC 部门: Healthcare 工业: Biotechnology
最后更新时间2 May 2024 @ 03:57

-0.51% $ 89.14

Live Chart Being Loaded With Signals

Commentary (2 May 2024 @ 03:57):

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally...

Stats
今日成交量 50 646.00
平均成交量 34 347.00
市值 86.15B
Last Dividend $0.645 ( 2023-09-08 )
Next Dividend $0 ( N/A )
P/E 35.09
ATR14 $0.579 (0.65%)

音量 相关性

長: 0.08 (neutral)
短: 0.62 (weak)
Signal:(47.236) Neutral

CSL Limited 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

CSL Limited 相关性 - 货币/商品

The country flag -0.45
( neutral )
The country flag -0.56
( weak negative )
The country flag -0.49
( neutral )
The country flag -0.39
( neutral )
The country flag 0.35
( neutral )

CSL Limited 财务报表

Annual 2023
营收: $13.17B
毛利润: $6.71B (50.92 %)
EPS: $2.27
FY 2023
营收: $13.17B
毛利润: $6.71B (50.92 %)
EPS: $2.27
FY 2022
营收: $10.49B
毛利润: $5.66B (53.97 %)
EPS: $2.40
FY 2021
营收: $10.27B
毛利润: $5.80B (56.49 %)
EPS: $2.62

Financial Reports:

No articles found.

CSL Limited Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.590
(N/A)
$0
(N/A)
$0.535
(N/A)
$0
(N/A)
$0.645
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

CSL Limited Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.66 - Stable (13.14%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.158 2010-03-10
Last Dividend $0.645 2023-09-08
Next Dividend $0 N/A
Payout Date 2023-09-09
Next Payout Date N/A
# dividends 28 --
Total Paid Out $10.42 --
Avg. Dividend % Per Year 0.00% --
Score 4.02 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 5.66
Div. Directional Score 9.13 --
Next Divdend (Est)
(2024-07-01)
$0.671 Estimate 7.55 %
Dividend Stability
0.30 Poor
Dividend Score
4.02
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
RMYHY Ex Dividend Knight 2023-09-05 Semi-Annually 0 0.00%
FCELB Ex Dividend Junior 2023-07-31 Semi-Annually 0 0.00%
WDFN Ex Dividend Junior 2023-08-10 Quarterly 0 0.00%
LRENY Ex Dividend Knight 2023-06-30 Quarterly 0 0.00%
CIWV Ex Dividend Knight 2023-07-20 Quarterly 0 0.00%
SKLTY Ex Dividend Junior 2023-09-05 Annually 0 0.00%
GTPS Ex Dividend Knight 2023-09-14 Quarterly 0 0.00%
AILLM Ex Dividend Knight 2023-07-14 Quarterly 0 0.00%
NCBDF Ex Dividend Junior 2023-09-28 Annually 0 0.00%
COIHY Ex Dividend Knight 2023-08-31 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1771.5006.459.68[0 - 0.5]
returnOnAssetsTTM0.1181.2006.067.27[0 - 0.3]
returnOnEquityTTM0.2121.5008.7610.00[0.1 - 1]
payoutRatioTTM0.258-1.0007.42-7.42[0 - 1]
currentRatioTTM2.150.8004.253.40[1 - 3]
quickRatioTTM0.9710.8009.007.20[0.8 - 2.5]
cashRatioTTM0.2161.5009.9110.00[0.2 - 2]
debtRatioTTM0.282-1.5005.30-7.95[0 - 0.6]
interestCoverageTTM9.551.0007.587.58[3 - 30]
operatingCashFlowPerShareTTM4.172.008.6110.00[0 - 30]
freeCashFlowPerShareTTM2.002.009.0010.00[0 - 20]
debtEquityRatioTTM0.612-1.5007.55-10.00[0 - 2.5]
grossProfitMarginTTM0.4981.0005.045.04[0.2 - 0.8]
operatingProfitMarginTTM0.2501.0007.017.01[0.1 - 0.6]
cashFlowToDebtRatioTTM0.3831.0008.998.99[0.2 - 2]
assetTurnoverTTM0.6660.8008.897.11[0.5 - 2]
Total Score12.60

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM19.631.0008.120[1 - 100]
returnOnEquityTTM0.2122.509.2010.00[0.1 - 1.5]
freeCashFlowPerShareTTM2.002.009.3310.00[0 - 30]
dividendYielPercentageTTM1.3841.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM4.172.008.6110.00[0 - 30]
payoutRatioTTM0.2581.5007.42-7.42[0 - 1]
pegRatioTTM-3.621.500-10.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1621.0008.450[0.1 - 0.5]
Total Score5.66

CSL Limited

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。